Life Science company Orexa raises €585,000

Orexa BV, the North Brabant-based life sciences company developing a new drug that increases food intake and supports patient health, has completed a financing round of €585,000. The investment will be used to prepare for Orexa's Phase 2b/3 clinical program, aimed at the prevention of postoperative ileus. Postoperative ileus is a temporary cessation of bowel function that occurs after surgery, particularly abdominal surgery.